1. Home
  2. AIN vs NVCR Comparison

AIN vs NVCR Comparison

Compare AIN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Albany International Corporation

AIN

Albany International Corporation

HOLD

Current Price

$56.82

Market Cap

1.7B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$10.86

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIN
NVCR
Founded
1895
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Textiles
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
AIN
NVCR
Price
$56.82
$10.86
Analyst Decision
Hold
Buy
Analyst Count
4
6
Target Price
$60.25
$28.08
AVG Volume (30 Days)
229.2K
1.0M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
2.00%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$1,054,132,000.00
$655,353,000.00
Revenue This Year
$1.20
$7.72
Revenue Next Year
N/A
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
7.29
8.28
52 Week Low
$41.15
$9.82
52 Week High
$73.00
$20.05

Technical Indicators

Market Signals
Indicator
AIN
NVCR
Relative Strength Index (RSI) 58.71 42.85
Support Level $54.15 N/A
Resistance Level $60.43 $13.59
Average True Range (ATR) 1.67 0.55
MACD 0.64 -0.06
Stochastic Oscillator 96.34 33.49

Price Performance

Historical Comparison
AIN
NVCR

About AIN Albany International Corporation

Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: